Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2025-12-27 @ 4:18 AM
Study NCT ID:
NCT05660395
Status:
RECRUITING
Last Update Posted:
2025-07-16
First Post:
2022-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)
Sponsor:
ADC Therapeutics S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-13
First Submit QC Date:
None
Study First Post Date:
2022-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-14
Last Update Post Date:
2025-07-16
Last Update Post Date Type:
ACTUAL